SLFN11 and age-related macular degeneration: In addition, clinical validation studies are carried out to evaluate their value as biomarkers and explore their application potential in personalized treatment to better understand the biological functions and clinical significance of SLFN11 and GRIN1 in AMD and to provide a solid theoretical basis and practical guidance for the diagnosis and treatment of AMD.